Compare Heron Therapeutics Inc (HRTX) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs KraneShares CSI China Internet ETF — how do they compare? Heron Therapeutics Inc trades at $0.38 (market cap $68.01M), while KraneShares CSI China Internet ETF trades at $24.79 (market cap $4.37B). The key difference: KraneShares CSI China Internet ETF is far larger — about 64.3× Heron Therapeutics Inc's market cap, and KraneShares CSI China Internet ETF is more actively traded (13,393,361 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| HRTX | KWEB | |
|---|---|---|
Market Cap | $68.01M | $4.37B |
Volume | 1,891,941 | 13,393,361 |
Sector | Health | Sector/Thematic |
52-Week High | $1.49 | $41.35 |
52-Week Low | $0.27 | $23.63 |
Typical Hold Time | 35 Days | 57 Days |
Enterprise Value | $174.75M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
KWEB trades at $24.87, up 2.22% with bearish technical signals from moving averages and neutral oscillators. Recent news highlights institutional position changes and China-focused economic developments. The ETF faces headwinds from U.S.-China trade dynamics and Chinese industrial overcapacity concerns.
The outlook remains cautious due to geopolitical risks and technical weakness. Investment opportunities exist for those bullish on China's internet sector recovery, but risks include trade tensions and economic rebalancing pressures that could impact performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
